| 000 | 01229 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250516170931.0 | ||
| 264 | 0 | _c20140310 | |
| 008 | 201403s 0 0 chi d | ||
| 022 | _a0376-2491 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aXi, Yan-hai | |
| 245 | 0 | 0 |
_a[Osteogenetic capacity of cross-linked adjustable anti-tuberculosis drug sustained-release artificial composite]. _h[electronic resource] |
| 260 |
_bZhonghua yi xue za zhi _cMay 2013 |
||
| 300 |
_a1494-8 p. _bdigital |
||
| 500 | _aPublication Type: English Abstract; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibiotics, Antitubercular _xadministration & dosage |
| 650 | 0 | 4 | _aArtificial Organs |
| 650 | 0 | 4 |
_aBone Regeneration _xdrug effects |
| 650 | 0 | 4 | _aDelayed-Action Preparations |
| 650 | 0 | 4 | _aNanostructures |
| 650 | 0 | 4 |
_aOsteogenesis _xdrug effects |
| 650 | 0 | 4 | _aRabbits |
| 650 | 0 | 4 |
_aRifampin _xadministration & dosage |
| 650 | 0 | 4 | _aTissue Engineering |
| 700 | 1 | _aXue, Min-tao | |
| 700 | 1 | _aYe, Xiao-jian | |
| 700 | 1 | _aXu, Ning | |
| 700 | 1 | _aQu, Jin-tao | |
| 700 | 1 | _aLiu, Xi-lin | |
| 700 | 1 | _aHe, Hai-long | |
| 773 | 0 |
_tZhonghua yi xue za zhi _gvol. 93 _gno. 19 _gp. 1494-8 |
|
| 999 |
_c23082018 _d23082018 |
||